Balchem Corp. (BCPC)
153.35
-0.70
(-0.45%)
USD |
NASDAQ |
Dec 04, 16:00
153.25
-0.10
(-0.07%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.966B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -14.16% |
| Valuation | |
| PE Ratio | 33.57 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.941 |
| Price to Book Value | 3.827 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.87 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.1325 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 33.89% |
Profile
| Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ. |
| URL | http://www.balchem.com |
| Investor Relations URL | https://balchem.com/investors/ |
| HQ State/Province | New Jersey |
| Sector | Materials |
| Industry | Chemicals |
| Next Earnings Release | Feb. 20, 2026 (est.) |
| Last Earnings Release | Oct. 21, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 26, 2024 |
Ratings
Profile
| Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ. |
| URL | http://www.balchem.com |
| Investor Relations URL | https://balchem.com/investors/ |
| HQ State/Province | New Jersey |
| Sector | Materials |
| Industry | Chemicals |
| Next Earnings Release | Feb. 20, 2026 (est.) |
| Last Earnings Release | Oct. 21, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 26, 2024 |